NCT05823935

Brief Summary

To compare vaginal cuff closure via Bakay purse string with vaginal cuff closure via vaginal route with continuous locked suturing after total laparoscopic hysterectomy for benign lesions.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 5, 2022

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 9, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 21, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2023

Completed
Last Updated

April 21, 2023

Status Verified

April 1, 2023

Enrollment Period

12 months

First QC Date

April 9, 2023

Last Update Submit

April 9, 2023

Conditions

Keywords

TLHBakay purse string

Outcome Measures

Primary Outcomes (2)

  • Total operative time

    The time between placement of the operative ports and successful closure of the vaginal cuff

    From start to end of operation

  • Operative time for colpotomy and vaginal cuff closure

    The time between first anchor suture placement and successful closure of the vaginal cuff

    From start colpotomy to end of vaginal cuff closure

Study Arms (2)

Bakay purse string group

ACTIVE COMPARATOR

Bakay purse string will be used to close the vaginal cuff after total laparoscopic hysterectomy for benign lesions.

Procedure: Bakay purse string

Cuff closure via vaginal route group

ACTIVE COMPARATOR

Vaginal cuff closure via vaginal route with continuous locked suturing will be used to close the vaginal cuff after total laparoscopic hysterectomy for benign lesions.

Procedure: Cuff closure via vaginal route group

Interventions

After developing the bladder flap, Vicryl polyglactin 910 sutures (Ethicon, Inc, Somerville, NJ) will be placed on the line between the cervicovaginal junction and the bladder starting at either 4 to 3 o'clock or 8 to 9 o'clock, as anchor sutures. Paying attention not to get closer than 1 cm to the bladder, the first suture will be passed from 4 o'clock to 3 o'clock and continued circumferentially in a full-thickness purse string fashion through 3, 1, 10, 8, 7, 5 o'clock completing a circle while including both uterosacral ligaments.

Bakay purse string group

After the uterus will be removed via vaginal route, vaginal cuff ends will be grasped via vaginal approach and sutured continuous locked sutures using Vicryl polyglactin 910 sutures in one layer.

Cuff closure via vaginal route group

Eligibility Criteria

Age30 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Benign uterine lesions e.g fibroid, adenomyosis,…etc.
  • Patient acceptance to undergo laparoscopic hysterectomy.

You may not qualify if:

  • Gynecological malignancy.
  • Low corporeal myoma obsecuring cervicovaginal junction.
  • History of extensive abdominal surgery other than cesarean section.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Obstetrics and Gynecology Department in Mansoura University Hospital

Al Mansurah, Dakahlia Governorate, 35111, Egypt

RECRUITING

MeSH Terms

Conditions

Uterine Diseases

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

  • Ahmed M Elashry, MSc

    Mansoura University

    PRINCIPAL INVESTIGATOR
  • Hamed M Youssef, MD

    Mansoura University

    STUDY CHAIR
  • Maged R Elshamy, MD

    Mansoura University

    STUDY DIRECTOR
  • Mahmoud M Awad, MD

    Mansoura University

    STUDY DIRECTOR
  • Mohamed S Abdelhafez, MD

    Mansoura University

    STUDY DIRECTOR

Central Study Contacts

Ahmed M Elashry, MSc

CONTACT

Mohamed S Abdelhafez, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 9, 2023

First Posted

April 21, 2023

Study Start

November 5, 2022

Primary Completion

November 1, 2023

Study Completion

November 1, 2023

Last Updated

April 21, 2023

Record last verified: 2023-04

Locations